Reilly Financial Advisors’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Reilly Financial Advisors’s Portfolio PBE Stock Details PBE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$21K	Hold	300	–	–	﹤0.01%	567
2021 Q3	$22K	Hold	300	–	–	﹤0.01%	507
2021 Q2	$23K	Hold	300	–	–	﹤0.01%	528
2021 Q1	$22K	Hold	300	–	–	﹤0.01%	522
2020 Q4	$21K	Hold	300	–	–	﹤0.01%	485
2020 Q3	$17K	Hold	300	–	–	﹤0.01%	471
2020 Q2	$17K	Hold	300	–	–	﹤0.01%	481
2020 Q1	$14K	Hold	300	–	–	﹤0.01%	490
2019 Q4	$17K	Hold	300	–	–	﹤0.01%	538
2019 Q3	$14K	Hold	300	–	–	﹤0.01%	579
2019 Q2	$16K	Hold	300	–	–	﹤0.01%	580
2019 Q1	$17K	Hold	300	–	–	﹤0.01%	568
2018 Q4	$14K	Hold	300	–	–	﹤0.01%	576
2018 Q3	$18K	Hold	300	–	–	﹤0.01%	584
2018 Q2	$16K	Hold	300	–	–	﹤0.01%	567
2018 Q1	$15K	Hold	300	–	–	﹤0.01%	563
2017 Q4	$14K	Hold	300	–	–	﹤0.01%	579
2017 Q3	$15K	Hold	300	–	–	﹤0.01%	558
2017 Q2	$14K	Hold	300	–	–	﹤0.01%	583
2017 Q1	$13K	Hold	300	–	–	﹤0.01%	560
2016 Q4	$12K	Hold	300	–	–	﹤0.01%	530
2016 Q3	$13K	Hold	300	–	–	﹤0.01%	476
2016 Q2	$11K	Buy	+300	New	+$11.8K	﹤0.01%	491
2015 Q4	–	Sell	-300	Closed	-$14.8K	–	1330
2015 Q3	$14K	Hold	300	–	–	﹤0.01%	695
2015 Q2	$18K	Sell	300 -300	-50%	-$17.2K	﹤0.01%	706
2015 Q1	$33K	Hold	600	–	–	0.01%	520
2014 Q4	$30K	Hold	600	–	–	0.01%	326
2014 Q3	$28K	Hold	600	–	–	0.01%	337
2014 Q2	$27K	Hold	600	–	–	0.01%	358
2014 Q1	$25K	Hold	600	–	–	0.01%	387
2013 Q4	$22K	Buy	+600	New	+$21.5K	0.01%	375

Other funds holding PBE

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AWA

Artemis Wealth Advisors New York $662M AUM 39.67% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

ACM

Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return

PFG Advisors Phoenix, Arizona $1.98B AUM 28.18% 1-Year Est. Return

Reilly Financial Advisors's PBE Position: Q4 2021 in Review

Reilly Financial Advisors held its Invesco Biotechnology & Genome ETF (PBE) position steady in Q4 2021 at 300 shares worth $21K. The position accounts for ﹤0.01% of the portfolio, ranked #567.

Reilly Financial Advisors first reported a position in PBE in Q4 2013 and has held it in 31 quarters since. The position peaked at $33K in Q1 2015. 101 funds tracked by Wall St. Rank hold PBE as of Q4 2021.

Reilly Financial Advisors held 300 shares of Invesco Biotechnology & Genome ETF worth $21K as of Q4 2021.
Reilly Financial Advisors left its Invesco Biotechnology & Genome ETF share count unchanged in Q4 2021.
Invesco Biotechnology & Genome ETF made up ﹤0.01% of Reilly Financial Advisors's portfolio in Q4 2021, its #567 holding.
Reilly Financial Advisors first reported a position in Invesco Biotechnology & Genome ETF in Q4 2013 and has held it in 31 quarters since.
Reilly Financial Advisors's Invesco Biotechnology & Genome ETF position peaked at $33K in Q1 2015.
101 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q4 2021.

Based on Reilly Financial Advisors's 13F filing for Q4 2021, filed 25 Jan 2022.